Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
16.02
Dollar change
-0.17
Percentage change
-1.05
%
Index- P/E- EPS (ttm)-3.46 Insider Own0.41% Shs Outstand98.72M Perf Week-7.13%
Market Cap1.58B Forward P/E- EPS next Y-1.81 Insider Trans-8.59% Shs Float98.31M Perf Month-22.98%
Income-334.62M PEG- EPS next Q-0.51 Inst Own42.47% Short Float3.73% Perf Quarter-38.50%
Sales266.72M P/S5.93 EPS this Y9.15% Inst Trans-2.02% Short Ratio5.50 Perf Half Y-36.58%
Book/sh8.19 P/B1.96 EPS next Y42.50% ROA-29.66% Short Interest3.66M Perf Year-52.66%
Cash/sh8.17 P/C1.96 EPS next 5Y- ROE-36.34% 52W Range15.69 - 40.42 Perf YTD-41.38%
Dividend Est.- P/FCF- EPS past 5Y-16.93% ROI-41.61% 52W High-60.37% Beta1.10
Dividend TTM- Quick Ratio4.41 Sales past 5Y2095.12% Gross Margin64.08% 52W Low2.10% ATR (14)1.05
Dividend Ex-Date- Current Ratio4.63 EPS Y/Y TTM25.17% Oper. Margin-141.19% RSI (14)32.55 Volatility3.93% 5.18%
Employees2175 Debt/Eq0.02 Sales Y/Y TTM24.03% Profit Margin-125.46% Recom1.17 Target Price54.76
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-52.98% Payout- Rel Volume1.17 Prev Close16.19
Sales Surprise-8.76% EPS Surprise-90.47% Sales Q/Q5.16% EarningsFeb 27 AMC Avg Volume665.79K Price16.02
SMA20-13.96% SMA50-20.66% SMA200-35.75% Trades Volume780,150 Change-1.05%
Date Action Analyst Rating Change Price Target Change
Dec-14-23Initiated Morgan Stanley Overweight $47.50
Aug-10-23Initiated Cantor Fitzgerald Overweight $70
Jan-21-22Initiated Macquarie Outperform $64
Oct-12-21Initiated Bernstein Mkt Perform
Apr-28-20Initiated Goldman Buy
Apr-15-20Initiated Guggenheim Buy $75
Jul-12-19Initiated BofA/Merrill Buy
Jul-05-19Initiated Macquarie Outperform
Jan-29-19Initiated Credit Suisse Outperform
Nov-21-18Initiated Jefferies Buy
Mar-27-24 09:29AM
Mar-20-24 04:30PM
Mar-19-24 07:01PM
Mar-13-24 07:05PM
Mar-06-24 04:01PM
07:30AM Loading…
07:30AM
Mar-01-24 10:12AM
Feb-29-24 08:51AM
Feb-27-24 04:38PM
04:05PM
Feb-25-24 09:32PM
Jan-25-24 04:15PM
Jan-10-24 05:12PM
Jan-04-24 07:02PM
Dec-22-23 12:00PM
07:30AM Loading…
Dec-19-23 07:30AM
Dec-13-23 08:53AM
Dec-12-23 11:10PM
Nov-23-23 09:42AM
Nov-09-23 02:39PM
Nov-07-23 04:05PM
Oct-26-23 07:30AM
Oct-18-23 07:30AM
Oct-17-23 08:25AM
Oct-14-23 01:15PM
Sep-21-23 04:48PM
Sep-18-23 07:30AM
Sep-05-23 11:16AM
09:23AM
Aug-31-23 09:16AM
07:30AM Loading…
Aug-30-23 07:30AM
Aug-29-23 07:38AM
Aug-10-23 10:12AM
Aug-07-23 04:05PM
Jul-28-23 03:57PM
Jul-20-23 07:30AM
Jul-19-23 07:30AM
Jul-17-23 01:03AM
Jul-14-23 07:30AM
Jul-10-23 07:30AM
Jul-06-23 04:05PM
Jun-30-23 11:20AM
09:22AM
Jun-28-23 07:30AM
Jun-12-23 08:56AM
Jun-07-23 11:05AM
Jun-06-23 08:05AM
Jun-01-23 04:03PM
May-25-23 07:30AM
May-24-23 08:01AM
May-22-23 11:11AM
May-18-23 07:30AM
May-15-23 02:57PM
May-10-23 11:53AM
May-09-23 04:01PM
May-03-23 09:58PM
Apr-27-23 07:30AM
Apr-26-23 10:25AM
Apr-20-23 07:30AM
Apr-18-23 01:55PM
Apr-14-23 03:32AM
Apr-11-23 08:03AM
Mar-26-23 07:45AM
Mar-20-23 06:35AM
Mar-17-23 07:19AM
06:59AM
Mar-10-23 06:55AM
Mar-08-23 09:06AM
Mar-06-23 09:55AM
08:30AM
Mar-03-23 12:55PM
Mar-01-23 04:01PM
Feb-28-23 07:30AM
Feb-22-23 04:30PM
07:30AM
Feb-09-23 07:30AM
Feb-07-23 05:36AM
Jan-31-23 07:30AM
Jan-30-23 07:30AM
Jan-27-23 02:56PM
Jan-18-23 07:49AM
Jan-16-23 02:18AM
Jan-09-23 07:30AM
Jan-05-23 03:50PM
10:21AM
10:19AM
08:57AM
07:34AM
Jan-03-23 08:30AM
Jan-01-23 08:13AM
Dec-20-22 07:30AM
Dec-19-22 08:38AM
Dec-15-22 04:05PM
Dec-05-22 06:10PM
Nov-12-22 08:05AM
Nov-09-22 04:01PM
Nov-08-22 08:30AM
07:30AM
Nov-04-22 08:24AM
Oct-31-22 07:52AM
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Edmondson Frazor Titus IIIChief Legal OfficerMar 15 '24Sale18.7110,000187,12720,005Mar 19 04:12 PM
Amado RafaelSee RemarksMar 15 '24Sale18.862,54447,98020,093Mar 19 04:12 PM
Smiley Joshua LSee RemarksMar 01 '24Buy20.833,00062,49023,527Mar 04 04:28 PM
Du YingChairperson & CEOJan 03 '24Sale26.128,380218,9021,133,450Jan 03 07:25 PM
Edmondson Frazor Titus IIIChief Legal OfficerJan 03 '24Sale26.124,803125,46430,005Jan 03 07:25 PM
Reinhart HaraldSee RemarksJan 03 '24Sale26.124,803125,46446,060Jan 03 07:25 PM
Amado RafaelSee RemarksJan 02 '24Sale26.3019,363509,16922,637Jan 03 07:26 PM
Smiley Joshua LSee RemarksDec 14 '23Buy29.904,000119,60020,527Dec 18 05:08 PM
Smiley Joshua LSee RemarksNov 16 '23Buy26.935,000134,65016,527Nov 16 06:04 PM
Chen YajingChief Financial OfficerNov 02 '23Sale25.231654,1636,982Nov 03 04:44 PM
Du YingChairperson & CEOJun 23 '23Option Exercise25.3058,8001,487,6401,055,913Jun 26 04:06 PM
Reinhart HaraldSee RemarksJun 23 '23Option Exercise25.3018,250461,72540,497Jun 26 04:07 PM
Edmondson Frazor Titus IIIChief Legal OfficerJun 23 '23Option Exercise25.3014,600369,38036,547Jun 26 04:05 PM
Cho William Ki ChulChief Financial OfficerApr 03 '23Option Exercise0.002,827053,747Apr 05 04:05 PM
Du YingChairperson & CEOMar 31 '23Option Exercise33.2614,200472,2921,006,951Apr 03 04:05 PM
Reinhart HaraldSee RemarksMar 31 '23Option Exercise33.264,348144,61423,060Apr 03 04:05 PM
Edmondson Frazor Titus IIIChief Legal OfficerMar 31 '23Option Exercise33.263,500116,41022,653Apr 03 04:05 PM